Matt Fearer
Vice President, Internal & External Communications @Viridian Therapeutics, Inc.
Signup · Get unlimited contacts
WORK HISTORY
Vice President, Internal & External Communications @Viridian Therapeutics, Inc.
Waltham, MA, US
Viridian Therapeutics is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridian’s expertise in antibody discovery and engineering enables it to develop differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The Company recently initiated its first global Phase 3 trial called ‘THRIVE’ to evaluate the safety and efficacy of VRDN-001 in patients with active TED.
EDUCATION
University of Pennsylvania
Bachelor’s Degree
Northwestern University
Master’s Degree
ABOUT MATT FEARER
Highly experienced communications professional with exceptional ability to develop strategic plans for communicating complex clinical, technical, and scientific issues for maximum impact. Polished, articulate institutional spokesperson experienced in liaising with business, medical, and media professionals. Highly skilled writer of executive communications, including speeches, Director’s letters, presentations, and event-related talking points.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.